(Q37115549)

18 August 2017

Reduced activities of cytochrome P450 1A2 and xanthine oxidase in children with growth hormone deficiency (English)

1 reference

growth hormone deficiency

18 August 2017

1 reference

M J Kennedy

1

1 reference

18 August 2017

D A Davis

2

1 reference

18 August 2017

N Smith

3

1 reference

18 August 2017

A Gaedigk

4

1 reference

18 August 2017

R E Pearce

5

1 reference

18 August 2017

G L Kearns

6

1 reference

18 August 2017

language of work or name

English

0 references

publication date

8 October 2008

1 reference

Clinical Pharmacology & Therapeutics

18 August 2017

1 reference

18 August 2017

84

1 reference

18 August 2017

6

1 reference

18 August 2017

674-678

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2008.185

18 August 2017

0 references

cites work

Ontogeny of dextromethorphan O- and N-demethylation in the first year of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Growth hormone regulation of sex-dependent liver gene expression

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Effects of obesity on the cytochrome P450 enzyme system.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Update: clinically significant cytochrome P-450 drug interactions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Effect of allopurinol on caffeine disposition in man.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Growth hormone inhibits the 11 beta-Hydroxysteroid dehydrogenase type 1 gene promoter activity via insulin-like growth factor I in HepG2 cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

A simple test for acetylator phenotype using caffeine

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Effect of human growth hormone on amobarbital metabolism in children.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in children

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Isoniazid pharmacokinetics in children according to acetylator phenotype

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Utah Growth Study: growth standards and the prevalence of growth hormone deficiency

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650481

Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity

3 September 2018

1 reference

12 December 2020

Update of guidelines for the use of growth hormone in children: the Lawson Wilkins pediatric endocrinology society drug and therapeutics committee

1 reference

12 December 2020

Changes in Drug Metabolism in Children with Thyroid Disorders

1 reference

12 December 2020

Pharmacokinetics of theophylline in children with asthma

1 reference

12 December 2020

Effects of growth hormone on antipyrine kinetics in children

1 reference

12 December 2020

Effect of growth hormone on human drug metabolism: time course and substrate specificity

1 reference

12 December 2020

Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

1 reference

12 December 2020

The effect of methotrexate on the bioavailability of oral 6-mercaptopurine

1 reference

12 December 2020

A urinary metabolite ratio that reflects systemic caffeine clearance

1 reference

12 December 2020

Growth hormone increases rate of pubertal maturation

1 reference

12 December 2020

Caffeine as a metabolic probe: validation of its use for acetylator phenotyping

1 reference

12 December 2020

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test

1 reference

12 December 2020

Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man

1 reference

12 December 2020

Identifiers

DOI

10.1038/CLPT.2008.185

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

18843262

1 reference